Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Silk Road Medical Inc

SILK
Current price
27.49 USD 0 USD (0.00%)
Last closed 27.49 USD
ISIN US82710M1009
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 1 116 976 384 USD
Yield for 12 month +234.84 %
1Y
3Y
5Y
10Y
15Y
SILK
21.11.2021 - 28.11.2021

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. As of September 17, 2024, Silk Road Medical, Inc operates as a subsidiary of Boston Scientific Corporation. Address: 1213 Innsbruck Drive, Sunnyvale, CA, United States, 94089

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

20.75 USD

P/E ratio

Dividend Yield

Current Year

+177 134 000 USD

Last Year

+138 638 000 USD

Current Quarter

+51 242 000 USD

Last Quarter

+48 484 000 USD

Current Year

+127 086 000 USD

Last Year

+100 762 000 USD

Current Quarter

+38 506 000 USD

Last Quarter

+36 501 000 USD

Key Figures SILK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -57 552 000 USD
Operating Margin TTM -33.56 %
PE Ratio
Return On Assets TTM -14.11 %
PEG Ratio
Return On Equity TTM -36.45 %
Wall Street Target Price 20.75 USD
Revenue TTM 191 431 008 USD
Book Value 3.81 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 13.1 %
Dividend Yield
Gross Profit TTM 100 762 000 USD
Earnings per share -1.45 USD
Diluted Eps TTM -1.45 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -29.53 %

Dividend Analytics SILK

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SILK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation SILK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 5.3434
Price Sales TTM 5.8349
Enterprise Value EBITDA -12.8365
Price Book MRQ 7.221

Financials SILK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SILK

For 52 weeks

7.61 USD 27.51 USD
50 Day MA 27.17 USD
Shares Short Prior Month 3 191 940
200 Day MA 21 USD
Short Ratio 2.48
Shares Short 3 147 223
Short Percent 7.87 %